Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for over $4B.
Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for over $4B, including debt. Baxter International announced in March they were exploring a potential sale of their kidney care unit, initiated to separate it due to supply chain challenges and weak demand for dialysis operations. The deal could be announced in coming weeks if it materializes.
July 05, 2024
6 Articles